Log in

IXHL Incannex Healthcare Inc. NASDAQ · Australia

Incannex Healthcare (IXHL) news IXHL going concern, offering and Nasdaq notice news

Latest Incannex Healthcare news

  1. Listings

    Incannex Healthcare applies to move its listing to the Nasdaq Capital Market

    The transfer from the Nasdaq Global Market is part of the company's effort to meet Nasdaq continued listing requirements. Shares would keep trading as IXHL.

  2. Listings

    Incannex Healthcare Inc. gets Nasdaq minimum bid price notice, has until October 20, 2025

    Nasdaq told Incannex on April 23, 2025 that its shares had closed below $1.00 for 30 consecutive trading days, giving it until October 20, 2025 to regain compliance. Its annual report for the year ended June 30, 2024 carries an auditor's going concern paragraph.

  3. Listings

    Incannex gets Nasdaq deficiency notice on $50.0 million market value requirement

    Incannex Healthcare received a Nasdaq notice on January 3, 2025 that its market value of listed securities fell below the $50.0 million minimum for the Global Market. It has until July 2, 2025 to regain compliance, and its 2024 annual report carries a going-concern warning with $5.6 million of cash at June 30, 2024.

Incannex Healthcare annual financials

LineFY ended Jun 30, 2026FY ended Jun 30, 2025
Research and development$5.2 million$10.7 million
Net income (loss)-$19.3 million-$46.9 million
Cash from operations-$12.9 million-$12.5 million
Cash and equivalents$67.7 million$15.0 million

Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $67.7 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Incannex Healthcare

Has Incannex Healthcare issued a going-concern warning?

Our latest story on this, dated Apr 25, 2025: "Incannex Healthcare Inc. gets Nasdaq minimum bid price notice, has until October 20, 2025". The story links the filing or release it is based on. Read the story.

Has Incannex Healthcare raised money recently?

Our latest story on this, dated Jul 24, 2025: "Incannex Healthcare adds up to $100,000,000 to at-the-market stock program". The story links the filing or release it is based on. Read the story.

Has Incannex Healthcare received a Nasdaq deficiency notice?

Our latest story on this, dated Jan 10, 2025: "Incannex gets Nasdaq deficiency notice on $50.0 million market value requirement". The story links the filing or release it is based on. Read the story.

What is the ticker symbol of Incannex Healthcare?

Incannex Healthcare Inc. trades under the ticker IXHL on NASDAQ.

Where is Incannex Healthcare listed?

Incannex Healthcare Inc. is listed on NASDAQ.

What is the SEC CIK of Incannex Healthcare?

The SEC Central Index Key (CIK) for Incannex Healthcare Inc. is 1873875. Its filings are on SEC EDGAR.

How many shares does Incannex Healthcare have outstanding?

12,544,627 shares as of 2026-09-24, per the cover page of its 10-K filed 2026-09-25.

Which country or territory is Incannex Healthcare listed under?

Our directory records Incannex Healthcare Inc. under Australia.

What does Incannex Healthcare do?

Our directory classifies Incannex Healthcare Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Incannex Healthcare?

The ISIN recorded for Incannex Healthcare Inc. is US45333F2083.

Does aibio.space cover Incannex Healthcare?

aibio.space lists Incannex Healthcare Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is Incannex Healthcare incorporated?

SEC records list its state or country of incorporation as DE.

Is Incannex Healthcare profitable?

Incannex Healthcare Inc. reported a net loss of $19.3 million for the fiscal year ended Jun 30, 2026, and used $12.9 million of cash in operations, per its annual report to the SEC.

How much does Incannex Healthcare spend on research and development?

$5.2 million in the fiscal year ended Jun 30, 2026, per its annual report.

How much cash does Incannex Healthcare have?

$67.7 million in cash at Jun 30, 2026, per its 10-K.

Investor discussion: Incannex Healthcare

Members talk about Incannex Healthcare (IXHL). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Incannex Healthcare, newest first. Each line links the filing it comes from.

  1. Distress

    Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. Source

  2. Financings

    Announced a share repurchase program. SEC Form 8-K (Items 7.01,9.01). Source

  3. Financings

    Announced a share repurchase program. SEC Form 8-K (Items 7.01,9.01). Source

  4. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,8.01,9.01). Source

  5. Distress

    Reported the end of a material agreement. SEC Form 8-K (Items 1.02,7.01,8.01,9.01). Source

  6. Financings

    Reported a financing. SEC Form 8-K (Items 1.01,8.01,9.01). Source

  7. Listings

    Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,8.01,9.01). Source

  8. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01,9.01). Source

  9. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01,9.01). Source

  10. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01,9.01). Source

  11. Financings

    Reported a financing. SEC Form 8-K (Items 8.01,9.01). Source

  12. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source

  13. Financings

    Announced a share repurchase program. SEC Form 8-K (Items 8.01,9.01). Source

  14. Financings

    Reported a financing. SEC Form 424B5. Source

  15. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source

  16. Financings

    Reported a financing. SEC Form 8-K (Items 8.01,9.01). Source

  17. Financings

    Reported a financing. SEC Form 8-K (Items 1.01,1.02,5.02,5.03,5.07,9.01). Source

  18. Financings

    Reported a financing. SEC Form 8-K (Items 8.01,9.01). Source

  19. Listings

    Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source

  20. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,8.01). Source

  21. Financings

    Reported a financing. SEC Form 424B5. Source

  22. Listings

    Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. Source

  23. Financings

    Reported a financing. SEC Form 8-K (Items 1.01,3.02,8.01,9.01). Source

  24. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:IXHL on TradingView.

SEC filings and registration

SEC name
Incannex Healthcare Inc.
CIK
1873875
Industry (SIC)
Pharmaceutical Preparations (2834)
US tickers
IXHL (Nasdaq)
State or country of incorporation
DE
Fiscal year ends
June 30
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Business address
8 CENTURY CIRCUIT, NORWEST NSW
Phone
61 409 840 786
Shares outstanding
12,544,627 as of 2026-09-24 (10-K filed 2026-09-25)
Former names
Incannex Healthcare Ltd

Recent filings (8-K and 6-K are the company's own announcements)

  • 10-K filed 2026-09-25
  • 8-K filed 2026-09-09
  • 8-K filed 2026-08-25
  • 8-K filed 2026-08-11
  • 8-K filed 2026-07-23
  • 8-K filed 2026-06-25
  • 8-K filed 2026-06-10
  • 8-K filed 2026-06-09

Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

Listing details

Incannex Healthcare Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IXHL, recorded under Australia. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Incannex Healthcare Inc.
Ticker
IXHL
Listing
NASDAQ
Country or territory
Australia
Business scope
Biotechnology
ISIN
US45333F2083
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.